Koch will lead Client Services and strengthen strategic partnerships with pharma and biotech clientsGLADSTONE, ...
Recognition as Registered VC Positions Firm to Expand Investment in Japan’s Pharmaceutical Startup EcosystemNEW YORK--(BUSINESS WIRE)--B Capital, a global multi-stage investment firm, today announced ...
Acquisition Adds TUB-040, a NaPi2b Targeting ADC for Ovarian Cancer and other Solid Tumors, to Gilead Pipeline –– Industry ...
Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko” or the “Company”) is pleased to announce results from additional REE analysis on 32 samples from the Phase II soil sampling program at the Yellow Fox Property ...
Real-world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day ...
CaryHealth’s DTP platform modernizes the Natroba (spinosad) access experience, replacing fragmented virtual-care workflows with a seamless, patient-first modelWASHINGTON--(BUSINESS ...
Acquisition adds FDA‑ and DEA-accredited manufacturing facility to Parnell’s operationsSYDNEY, Australia--(BUSINESS WIRE)--Parnell today announced the acquisition of Noble Pharma LLC, a U.S.-based ...
The Princeton-based virtual care company partnered with DHC Group, PM360 and Researchscape to develop a comprehensive understanding of the benefits of virtual care in improving patient care and ...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that data ...
Invitation-only conference focuses on the evolving landscape of lung cancer risk and early detection when the disease is most treatablebioAffinity Technologies Chief Medical Officer Gordon Downie, MD, ...
The United States Air Force has awarded UES, a division of advanced research and development leader AeroVironment, Inc. (“AV”) (NASDAQ: AVAV), a three-year, $25M contract to transition innovative ...
Provides an automated, functionally closed approach to help address variability and support more reliable, consistent manufacturing outcomes  WALTHAM, Mass., April 2, 2026 — Thermo Fisher Scientific ...